Mayzent and Dysaesthesia - a phase IV clinical study of FDA data

Summary:

Dysaesthesia is reported only by a few people who take Mayzent.

The phase IV clinical study analyzes which people take Mayzent and have Dysaesthesia. It is created by eHealthMe based on reports of 7,239 people who have side effects while taking Mayzent from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

7,239 people reported to have side effects when taking Mayzent.
Among them, 3 people (0.04%) have Dysaesthesia.

What is Mayzent?

Mayzent has active ingredients of siponimod fumaric acid. eHealthMe is studying from 7,240 Mayzent users for its effectiveness, alternative drugs and more.

What is Dysaesthesia?

Dysaesthesia (abnormal sensation) is found to be associated with 998 drugs and 574 conditions by eHealthMe.

Number of Mayzent and Dysaesthesia reports submitted per year:

Time on Mayzent when people have Dysaesthesia *:

Gender of people who have Dysaesthesia when taking Mayzent *:

female: 100 %
male: 0.0 %

Age of people who have Dysaesthesia when taking Mayzent *:

Common drugs people take besides Mayzent *:

Nexium: 1 person, 33.33%
Fingolimod: 1 person, 33.33%
Alprazolam: 1 person, 33.33%

Common side effects people have besides Dysaesthesia *:

White Blood Cell Count Decreased: 3 people, 100.00%
Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 3 people, 100.00%
Muscle Spasms (muscle contraction): 3 people, 100.00%
Lymphocyte Count Decreased: 3 people, 100.00%
Lhermitte's Sign (an electrical sensation that runs down the back and into the limbs): 3 people, 100.00%
Hyperreflexia (overactive or over responsive reflexes): 3 people, 100.00%
Gait Disturbance: 3 people, 100.00%
Depressive Symptom: 3 people, 100.00%
Sudden Hearing Loss: 1 person, 33.33%
Dizziness: 1 person, 33.33%

Common conditions people have *:

Secondary Progressive Multiple Sclerosis (a stage of ms which comes after relapsing remitting ms in many cases): 3 people, 100.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 3 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Mayzent and have Dysaesthesia?

Check whether Dysaesthesia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Dysaesthesia and when was it recovered:

Dysaesthesia in Mayzent

Expand to all the drugs that have ingredients of siponimod fumaric acid:

Dysaesthesia and drugs with ingredients of siponimod fumaric acid

Alternative drugs to, pros and cons of Mayzent:

Mayzent (7,240 reports)

Common Mayzent side effects:

Fatigue (feeling of tiredness): 938 reports
Headache (pain in head): 822 reports
Dizziness: 658 reports
Weakness: 500 reports
High blood pressure: 365 reports
Memory loss: 361 reports
Drug ineffective: 351 reports

Browse all side effects of Mayzent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Dysaesthesia treatments and more:

Dysaesthesia (3,631 reports)

COVID vaccines that are related to Dysaesthesia:

Common drugs associated with Dysaesthesia:

All the drugs that are associated with Dysaesthesia:

Dysaesthesia (998 drugs)

Common conditions associated with Dysaesthesia:

All the conditions that are associated with Dysaesthesia:

Dysaesthesia (574 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on siponimod fumaric acid (the active ingredients of Mayzent) and Mayzent (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.